Alr Technologies Inc (ALRT) 0.0013 $ALRT ALRT Introduces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alr Technologies Inc (ALRT) 0.0013 $ALRT

ALRT Introduces Value Pricing for Diabetes Management
GlobeNewswire - Tue Dec 22, 8:25AM CST
Medical practices, health insurers, self-insured employers, and other potential users of the ALRT diabetes management system can now choose a pricing plan linked to declines in a patient's A1C level. The plan is designed to eliminate performance risk and to provide rewards for achieving measurable health goals.

ALRT System Significantly Lowers A1C Levels in Type 2 Diabetes Patients in Real World Pilot Program
GlobeNewswire - Tue Nov 17, 8:37AM CST
A 10-month pilot of the ALRT remote monitoring system for diabetes by the Kansas City Metropolitan Physician Association (KCMPA) has found significant improvement in glycemic control for those patients who used the system compared to those who dropped out of the pilot.

Global Remote Patient Monitoring Pipeline Report 2015
M2 - Thu May 14, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/djkt2t/remote_patient) has announced the addition of the "Remote Patient Monitoring - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key remote patient monitoring pipeline products. Scope - Extensive coverage of the Remote Patient Monitoring products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Remote Patient Monitoring and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Remote Patient Monitoring Companies and Product Overview - ActiveCare, Inc. - Agali Technologies, Inc. - AirStrip Technologies, Inc. - ALR Technologies Inc. - Barron Associates, Inc. - BioSensics LLC - Bio-Signal Group Corp. - Boston Scientific Corporation - BrightOutcome Inc. - CellAegis Devices Inc. - autoRIC Device Clinical Trial Details - CorTronix Biomedical Advancement Technologies, Inc. - CurePatch Inc - Dartmouth College - Futura Mobile Health, LLC - Great Lakes NeuroTechnologies - BradyXplore - Guide Analytics Inc. - Ibridge Medical, LLC - JointMetrix Medical, LLC - Kyma Medical Technologies Ltd - OBS Medical Ltd. - PerGenix LLC - Philips Healthcare - Sensogo Ltd. - Sister Kenny Research Center - SPO Global Inc. - The Johns Hopkins University - Thoratec Corporation - Universitat Politecnica de Catalunya - University of New Mexico - University of Toronto - Waldo Health - WANDA Inc - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/dj...te_patient
BSX: 24.17 (+0.21), THOR: 63.50 (+0.05)

ALR Technologies Signs First Revenue-Generating Contract
GlobeNewswire - Mon Apr 20, 7:37AM CDT
ALR Technologies Inc. (OTCQB:ALRT), a leading remote chronic care management and medical device company, is pleased to announce that Clay-Platte Family Medicine Clinic, one of the largest primary care clinics in the Northland of Kansas City, has signed a contract with ALRT to improve diabetes health outcomes using the Health-e-Connect remote chronic care management system.

ALR Technologies Seeks FDA Approval For Insulin Dose Adjustment Feature for Better Diabetes Management
GlobeNewswire - Tue Feb 17, 7:25AM CST
ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for an innovative new addition to the Health-e-Connect system that will help busy physicians avoid common insulin dosing errors and remotely manage large populations of patients with diabetes without sacrificing the quality of care.

Nipro to Partner with ALR Technologies on Chilean Clinical Trial
GlobeNewswire - Tue Jan 20, 7:12AM CST
ALR Technologies Inc. (OTCQB: ALRT) announced that Nipro Diagnostics, Inc. and Nipro Medical Corporation have agreed to participate in a clinical outcomes study to be conducted by ALRT and Hospital Clinico Metropolitano La Florida, one of the largest and most prestigious public hospitals in Santiago, Chile. Nipro will provide its latest blood glucose meter, TRUE METRIX, to all participants in the trial as well as diagnostic supplies such as blood glucose test strips and data management cables. In addition, Nipro employees will assist with subject enrollment and other logistical tasks related to the pilot. Subject enrollment in the pilot is due to begin early next year.

ALRT System May Help Providers Meet Chronic Care Management Reimbursement Requirements
GlobeNewswire - Wed Jan 07, 7:38AM CST
Medical practices may be able to secure new revenue while they improve outcomes for patients with diabetes by using Health-e-Connect, the remote diabetes care management system from ALR Technologies Inc. (OTCQB: ALRT).

ALR Technologies Advocates For Sensible Medicare Reimbursement of Continuous Glucose Monitoring (CGM) for Diabetes Patients
Marketwired - Mon Oct 20, 7:18AM CDT
In a letter to Marilyn Tavenner, Administrator of the Center for Medicare and Medicaid Services (CMS), Bill Smith, President of ALR Technologies (OTCQB: ALRT) advocated for CMS reimbursement for continuous glucose monitoring systems (CGM) for Type 1 diabetes patients as well as higher-risk Type 2 patients. However, Smith argued that most Type 2 patients should first be encouraged to seek Internet-based remote chronic care management and then to step up to CGM if they don't achieve their health goals on the more cost-effective, Internet-based monitoring.

ALR Technologies Enters Latin America with Clinical Trials in Chile
ACCESSWIRE - Tue Oct 14, 7:01AM CDT
Richmond, VA / ACCESSWIRE / October 14, 2014 / ALR Technologies Inc. (OTC: ALRT) has signed an agreement to launch a clinical outcomes study in Chile as a potential solution to the growing number of diabetic patients in Latin America. ALRT's Health-e-Connect is the only off-the-shelf, FDA-cleared system to allow diabetic patients to remotely connect with physicians through a secure website, where Diabetes Care Facilitators (DCFs) regularly monitor the patients' data looking for readings outside of specified parameters.The upcoming trial follows ALRT's first large-scale commercial deployment of the Health-e-Connect system in the United States through the Kansas City Metropolitan Physicians Association in September. The Latin America trial will treat 100 diabetic patients in Santiago, Chile, with a successful trial expected to help establish a presence for ALRT in the large Latin American market.

Health-e-Connect: The FDA-Cleared System at the Forefront of Remote Diabetes Care
ACCESSWIRE - Tue Oct 07, 7:02AM CDT
Richmond, VA / ACCESSWIRE / October 7, 2014 / ALR Technologies' (ALRT) new FDA-cleared Remote Patient Monitoring system may finally allow doctors and clinicians to receive reimbursement for remote chronic care management, and it could become one of the most influential platforms for managing diabetes. ALRT's Health-e-Connect is the only off-the-shelf chronic care system connecting diabetes patients with an experienced care team as well their own physicians - anywhere in the country - through a secure and trusted website. If the Centers for Medicare and Medicaid Services (CMS) proposed payment schedule is finalized on November 1, physicians would receive payments of $41.92 for up to 20 minutes of remote care each month.Implementation of the proposed reimbursement plan would pave the way for ALRT to begin invoicing and collecting revenue for its services for diabetes patients covered by Medicare.Capturing just 1% of the US Medicare market as it pertains to diabetes would represent up to $2.3 million per month in potential revenue to ALRT.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 34

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 37

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 39

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 122

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 280

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 22

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 75

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 111

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Luckbox Stock Reaches New Low: Market Movements Explained

Updated Category News Views 326

Luckbox Stock Performance Overview The gaming and esports betting company, Luckbox, is currently navigating a fluctuating market landscape, with its stock price recently dipping to a notable 52-week low of $9.68. This shift is a pronounced departure from the previous year, reflecting ongoing challenges within the industry. As of now, the company's market capitalization...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 153

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Mirum Pharmaceuticals Presents Promising LIVMARLI Data at Conference

Updated Category News Views 107

Mirum Pharmaceuticals showcases LIVMARLI research findings Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has announced its participation in a significant scientific meeting where it aims to present groundbreaking data on LIVMARLI® (maralixibat) oral solution. This event is hosted by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition...

Continue Reading
Genmab Stock Faces Challenges, Yet Holds Hope for Recovery

Updated Category News Views 130

Genmab Stock Overview Genmab A/S Sponsored ADR (NASDAQ: GMAB) has recently experienced a turbulent period, with a notable decline of 14.7% in just four weeks. However, this decline has left the stock in an oversold position, igniting hope among investors as analysts anticipate improved earnings results. Understanding Oversold Conditions To assess whether a stock, such as...

Continue Reading
Challenges Ahead for Central Banks Tackling Inflation Variability

Updated Category News Views 117

Challenges Ahead for Central Banks in Addressing Inflation Fluctuations Inflation is a complex issue for policymakers, as recent comments from European Central Bank President Christine Lagarde illustrate. With substantial changes happening in the global economy, the prospect of stable inflation remains uncertain. Lagarde suggests that inflation may experience significant...

Continue Reading